- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Dasatinib Placebo
Total 54801 results
-
National Cancer Institute (NCI)CompletedGlioma | Brain Tumor | Glioblastoma Multiforme | Gliosarcoma | GBM | GSUnited States
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedChronic Phase Chronic Myeloid LeukemiaFrance, Italy, United States, Korea, Republic of, Germany
-
Bristol-Myers SquibbCompletedLeukemiaUnited States, Canada, Finland, Italy, United Kingdom, France, Germany
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompleted
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingHepatocellular Carcinoma Resectable
-
Tianjin Medical University Second HospitalUnknownSmall Cell Lung Cancer Extensive StageChina
-
Peking University People's HospitalPeking University Shougang Hospital; Peking University International HospitalWithdrawnAdvanced Cancer | Soft Tissue Sarcoma AdultChina
-
Washington University School of MedicineCompletedRelapsed, Refractory or Plateau Phase Multiple MyelomaUnited States
-
Baylor Breast Care CenterM.D. Anderson Cancer CenterTerminatedBreast CancerUnited States
-
Bristol-Myers SquibbCompletedLiver DiseasesUnited States
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Blast CrisisNetherlands, United States, Italy, Austria, Canada, France, Germany, Singapore, Taiwan, United Kingdom, Australia, Korea, Republic of, Philippines, Sweden, Finland, Israel, Belgium, Denmark, Norway, Switzerland
-
Federico II UniversityUniversity of BolognaUnknown
-
Sichuan UniversityBetta Pharmaceuticals Co., Ltd.Not yet recruitingNon-Small Cell Lung Cancer | ALK Fusion Protein Expression | Adjuvant Therapy
-
National Cancer Institute (NCI)TerminatedAccelerated Phase Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Relapsing Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingTreatment in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA MutationChina
-
HRYZ Biotech Co.Recruiting
-
Elevar TherapeuticsCompleted
-
Peking University Cancer Hospital & InstituteUnknown
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungKorea, Republic of, Taiwan, Singapore, Japan
-
Azienda Ospedaliera Ordine Mauriziano di TorinoUnknownMetastatic Breast CancerItaly
-
Boehringer IngelheimCompleted
-
NovartisApproved for marketingNeoplasms, BreastChina, United States, Spain, United Kingdom, Austria, Belgium, Estonia, Canada, Netherlands, Singapore, Australia, Germany, Israel, Italy, Poland, Russian Federation, Sweden, Switzerland, Taiwan, Thailand, Brazil, Denmark, Ireland, Korea... and more
-
GlaxoSmithKlineCompleted
-
University of California, San FranciscoNational Cancer Institute (NCI)CompletedBreast Cancer | Metastatic CancerUnited States
-
Guangxi Medical UniversityJiangsu HengRui Medicine Co., Ltd.RecruitingHepatocellular CarcinomaChina
-
Shanghai Zhongshan HospitalNot yet recruitingUnresectable Hepatocellular Carcinoma
-
M.D. Anderson Cancer CenterBristol-Myers Squibb; United States Department of DefenseCompleted
-
Duke UniversityBristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedChronic Myelogenous LeukemiaNetherlands, United States, Italy, Argentina, Brazil, Canada, Germany, Peru, Singapore, Taiwan, United Kingdom, France, Korea, Republic of, Philippines, Sweden, Thailand, Finland, Australia, Israel, Belgium, Denmark, Norway, Switzer...
-
Bristol-Myers SquibbCompletedBreast Cancer | MetastasisUnited States, Spain, Italy, France
-
Tianjin Hemay Oncology Pharmaceutical Co., LtdRecruiting
-
GlaxoSmithKlineCompleted
-
University of California, San FranciscoNational Cancer Institute (NCI)CompletedBreast Cancer | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Brain and Central Nervous System Tumors | Bladder Cancer | Extragonadal Germ Cell TumorUnited States
-
GlaxoSmithKlineCompletedNeoplasms, BreastSpain, Italy
-
AB ScienceCompletedHealthy VolunteersUnited Kingdom
-
Sichuan Cancer Hospital and Research InstituteJiangsu HengRui Medicine Co., Ltd.CompletedNasopharyngeal NeoplasmsChina
-
Wei JiangWuzhou Red Cross Hospital; Laibin People's Hospital; Guangxi Naxishan Hospital; People's Hospital of LingshanCompletedNasopharyngeal CarcinomaChina
-
First Affiliated Hospital Xi'an Jiaotong UniversityJiangsu HengRui Medicine Co., Ltd.UnknownLocally Advanced Gastric CancerChina
-
Jonsson Comprehensive Cancer CenterGlaxoSmithKlineCompletedBreast CancerUnited States
-
Istituto Clinico HumanitasCompleted
-
Second Affiliated Hospital, School of Medicine,...Not yet recruiting
-
Fudan UniversityNot yet recruiting
-
Shanghai Zhongshan HospitalUnknownHepatocellular CarcinomaChina
-
Shanghai Zhongshan HospitalUnknownHepatocellular CarcinomaChina
-
Yan LiJiangsu HengRui Medicine Co., Ltd.Unknown
-
Hebei Medical University Fourth HospitalUnknownRefractory or Metastatic Esophageal Squamous Cell CarcinomaChina
-
Chinese PLA General HospitalUnknown
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedPrimary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States